Buy Recommendation Issued On MBRX By Roth Capital

December 15, 2025 12:15:03 pm

Source: KlickAnalytics

2025-12-15 12:15:03 ET

Roth Capital analyst issues BUY recommendation for MBRX on December 15, 2025 05:17PM ET.

The previous analyst recommendation was Buy.

MBRX was trading at $4.63 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 4 - Buy recommendations .

Moleculin Biotech Inc.

-1.02% G/L:

$2.2598 Last:

19,282 Volume:

$2.18 Open:

March 27, 2026 09:15:00 am

March 20, 2026 07:00:34 am

March 19, 2026 08:36:00 am

March 17, 2026 09:05:00 am

Market Cap $11,205,089

Float 2,639,660

Insiders Ownership N/A

Institutions 11

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Houston